About us

HADASSAH AUSTRALIA MEDICAL RESEARCH & COLLABORATIONS FOUNDATION (HAMRC)

The HAMRC Foundation is a bold new initiative – a multi-centred collaborative research model that brings together the brightest minds from Israel’s Hadassah Hospital and leading research institutions in Australia and internationally to solve some of the most intractable health problems facing the world today.

Not only is Hadassah Hospital a pioneer in medical research, but it has received more patents than all other hospital-based research institutes in Israel combined.

HAMRC is the medical research arm of Hadassah Australia and a separate health promotion charity endorsed by the Australian Government.

HAMRC will turbo charge medical discovery in three important ways:

Stimulate new ideas and approaches by advancing and promoting cross-fertilisation of medical knowledge and expertise;
Create greater efficiency and capacity through the sharing of data, technology, equipment and laboratory resources;
Bring potential life-saving treatments to market quicker by fast-tracking the clinical trial process using Israel’s unique clinical trial ecosystem.

Donate

Donations can be used to provide seed-funding for translational research and clinical projects for accelerating the discoveries of new cures. Your gift enables important medical research with the aim of improving the quality of life for future generations.

Latest

Hadassah explores link between levels of anxiety and eating sweets

The study by Hadassah's Cardiovascular Wellness Center for Women found surprising results when comparing eating behaviours of patients with low, moderate, and high anxiety levels.
Hadassah to conduct clinical trial of Israeli-made Covid-19 vaccine

One hundred volunteers are being recruited for the trial, slated to begin in October at Hadassah and Tel Aviv's Sheba Medical Center.
Drug developed by Hadassah doctor helps severely ill Covid-19 patients

Hadassah Hospital successfully treated five seriously-ill COVID-19 patients using an experimental treatment. All five patients tested negative to coronavirus and have now been discharged.
The little things can make a big difference: Mental health during the COVID pandemic

Mental health experts from Australia and Israel discussed on Monday some of the consequences of COVID-19 and the practical ways to support one another through the crisis.

Donate

Donations can be used to provide seed-funding for translational research and clinical projects for accelerating the discoveries of new cures. Your gift enables important medical research with the aim of improving the quality of life for future generations.
The difference we can make together

Your philanthropic gift can be used to provide seed-funding for translational research and clinical projects for accelerating the discoveries of new cures.

Israel: The Connection

There is virtually no area of medical research to which Israel has not made significant contributions - cardiology, genetics, neurology and ophthalmology are but a few that have benefited.
Vision, mission, purpose

The HAMRC Foundation links the brightest researchers at Hadassah Hospital in Israel with their colleagues in Australia in order to solve the most pressing health issues facing the world.
Our board

The board oversees HAMRC’s mission including the assessment and funding of high-quality medical research collaborations which will ultimately lead to improve patient outcomes by accelerating the pace of biomedical discovery and the translation of medical breakthroughs into novel therapeutics and diagnostics.
Drug developed by Hadassah doctor helps severely ill Covid-19 patients

Hadassah Hospital successfully treated five seriously-ill COVID-19 patients using an experimental treatment. All five patients tested negative to coronavirus and have now been discharged.
Webinar—Coping with COVID: Safeguarding your mental health in the age of COVID-19

Register now for this live webinar bringing you expert tips and insights from some of Australia and Israel's leading mental health professionals.
Save the Next Steve Jobs from Terminal Pancreatic Cancer

Save the next Steve Jobs from terminal pancreatic cancer; harness Australia's medical know-how and Israel's clinical trial advantage.
Example - Where your money goes

Earn your supporters' trust by being transparent and making the impact of their support clear
Terms and Conditions
Hadassah Study Sheds Encouraging Light in Treating Liver Disease

The International Journal of Molecular Medicine has published a preclinical study led by Prof. Rifaat Safadi, head of the Hadassah Medical Center’s Liver Unit, that finds the oral drug Namodenoson induced significant anti-inflammatory, anti-steatotic (retention of lipids), and anti-fibrotic (scarring) effects caused by non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Example - Story/testimonial tips

Inspire visitors with real stories that humanise the impact you have, then call them to action